Non-aqueous injectable formulation preparation with pH adjusted for extended release of somatotropin
AssigneeMonsanto Technology LLC
InventorsDaniel N. Heintz, Yunhua N. Jeng
Life of this patent
Estimating the term…
Loading patent…
AssigneeMonsanto Technology LLC
InventorsDaniel N. Heintz, Yunhua N. Jeng
Estimating the term…
The present invention provides compositions of matter which allow for the extended release and enhanced bioavailability of biologically-active polypeptides following parenteral delivery to an animal. More particularly, it concerns compositions comprising biologically-active somatotropin formulated for extended release, methods of preparing these compositions, and methods of using the same. These compositions comprise somatotropin, a pH-adjusting constituent (PAC), and a substantially non-aqueous, hydrophobic excipient. The PAC may comprise any suitable, biocompatible compound including, but not limited to one or mixtures of two or more of the following: acetic acid, phosphoric acid, monobasic phosphate. The PAC is added to the compositions of matter in an amount effective to adjust the pH to or near to the isoelectric point (pI) of the somatotropin component.
A dry composition of matter comprising:
The composition of matter of 1 wherein the somatotropin is present at from about 20% to about 55% by weight.
The composition of matter of 11 wherein the substantially non-aqueous hydrophobic carrier is present from about 40% to about 80%, by weight.
The composition of matter of 15 wherein the somatotropin is present at from about 20% to about 55% by weight.
A method of making a composition of matter comprising somatotropin (ST), a pH-adjusting constituent (PAC), and a substantially non-aqueous hydrophobic carrier;
Dependencies are inferred from the claim text.